3C Company, Inc. News - Profile and Newsroom at Send2Press Newswire

3C Company, Inc. Newsroom - Profile and News Archive

3C Company, Inc. | Clintelligence solution, Business Performance Optimization, strategic business advantage for its pharmaceutical, biotechnology and medical device clients, 3C Company, Peter Oudheusden, business intelligence, BI implementation, pharma, Research and Development, Karen Briegs

Engage with 3C Company, Inc.

Follow:

Press Releases from 3C Company, Inc. :

U.S. Pharmaceuticals Spend $8 Billion Annually in R&D Conducted Overseas – New Clintelligence(R) Alignment Module Advances Global Management

Jun 12, 2007 6:00 PM EDT

KENILWORTH, N.J. – June 12 (SEND2PRESS NEWSWIRE) — 3C Company, Inc., a leading provider of Business Performance Optimization (BPO) solutions to the Life Sciences Industry, announces today the release of a new module to its highly successful Clintelligence(R) Business Intelligence Solution.

Drug Development Costs Exceed $802 Million: Global Pharmas Use Clintelligence to Do Something About It

May 2, 2007 7:00 PM EDT

KENILWORTH, N.J. – May 2, 2007 (SEND2PRESS NEWSWIRE) — 3C Company, Inc., a leading provider of Business Performance Optimization (BPO) solutions to the Life Sciences Industry, announced today that it has aligned with yet another Global Pharmaceutical Firm to implement Clintelligence – 3C Company’s Business Intelligence Solution for strategic and tactical oversight of their Research and Development portfolio.